Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.

NCT04232917 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papilloma Virus

Interventions

DRUG: 2LPAPI®
DRUG: Placebo

Sponsor

Labo'Life